How to Buy Corbus Pharmaceuticals Holdings Stock
Corbus Pharmaceuticals Holdings Inc
Corbus Pharmaceuticals Holdings, Inc. , a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases.
Corbus Pharmaceuticals Holdings stock last closed at $8.35, up 12.99% from the previous day, and has decreased 76.51% in one year. It has overperformed other stocks in the Biotechnology industry by 0.01 percentage points. Corbus Pharmaceuticals Holdings stock is currently +79.96% from its 52-week low of $4.64, and -86.51% from its 52-week high of $61.90.
At the moment, there are 12.23M shares of CRBP outstanding. The market value of CRBP is $102.14M. In the last 24 hours, 266,582 CRBP shares were traded.
How to Buy Corbus Pharmaceuticals Holdings Stock
Wondering how to invest in Corbus Pharmaceuticals Holdings stock? Here's how.
- Figure out where to buy Corbus Pharmaceuticals Holdings stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Corbus Pharmaceuticals Holdings stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your payment method and add your information.
- Analyze Corbus Pharmaceuticals Holdings stock: The Corbus Pharmaceuticals Holdings ticker symbol is CRBP. Is Corbus Pharmaceuticals Holdings stock a good investment? Should you buy shares of CRBP? How do CRBP's underlying business fundamentals look? Do top analysts think Corbus Pharmaceuticals Holdings is a good buy? Why has CRBP's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if CRBP is a good stock to buy).
- Execute your CRBP purchase: Decide if you will purchase CRBP shares at the current market price or use a limit order to purchase CRBP stock at a specific price.
- Monitor your investment in CRBP: Create a watchlist to get the latest news on your position in Corbus Pharmaceuticals Holdings shares.
Step 1: Figure out where to buy Corbus Pharmaceuticals Holdings stock
You need an online brokerage account in order to access the NASDAQ market and buy CRBP stock.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Tech to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal details so you are able to invest in CRBP today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open your new brokerage account.
- Submit your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've created your account on stock market apps, your next step is to transfer the money for your investment:
Check out the video below if you need help depositing funds into your investment account.
Step 4: Analyze Corbus Pharmaceuticals Holdings stock
Once you have identified the best place to buy Corbus Pharmaceuticals Holdings stock, it's critical to evaluate their stock before you invest, so you truly comprehend the risk and opportunity.
Overview of key CRBP info
Corbus Pharmaceuticals Holdings Fundamentals
WallStreetZen was created to help average investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CRBP's stock page.
Is CRBP stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CRBP's true value.
Using relative valuations ratios:
- CRBP could be undervalued based on its P/B ratio of 0.72x, relative to Biotechnology industry P/B ratio of 4.33x
You can access more valuation research on CRBP's stock here.
CRBP Financial Health
Positive Health Checks:
- CRBP has $149.73M in cash and short term investments. This is enough to cover its annual cash burn of $41.79M.
- CRBP has a low debt to equity ratio of 0.09.
- Total CRBP debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the CRBP balance sheet.
- CRBP has cash burn of 41794000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the CRBP balance sheet.
Is CRBP stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 4 Wall Street analysts who give ratings on CRBP, the consensus analyst rating on Corbus Pharmaceuticals Holdings is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Corbus Pharmaceuticals Holdings stock forecast page.
CRBP Technical Indicators
Is CRBP Making Money?
Last year, CRBP revenue was $0.00. Over the last 5 year, CRBP's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 44%.
You can research CRBP's earnings and revenue performance here.
Who is buying/selling CRBP?
In the past year, executives and large shareholders at CRBP have bought more shares than they have sold.
Dominic Smethurst, Chief Medical Officer of CRBP, was the latest CRBP insider to sell. They sold $43,331.75 worth of CRBP shares on Mar 6, 2025.
Research more about who owns CRBP shares here.
Can I get consistent income from CRBP stock?
No, Corbus Pharmaceuticals Holdings doesn't provide an income stream by paying out dividends.
CRBP Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your CRBP purchase
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact price limit, use a limit order.
Press the Open Trade button and eToro will execute the order.
If you want more assistance buying stocks on eToro, watch the helpful video below:
Step 6: Monitor your investment in CRBP
Now that you own some CRBP shares, you'll want to stay up-to-date on your investment.
Put CRBP on a watchlist to track your CRBP stock.
CRBP Feed
How to Buy Stock in Corbus Pharmaceuticals Holdings
To summarize, here are the 6 steps for buying Corbus Pharmaceuticals Holdings stock:
- Figure out where to buy Corbus Pharmaceuticals Holdings stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Analyze Corbus Pharmaceuticals Holdings stock
- Execute your CRBP purchase
- Monitor your investment in CRBP
If you require a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep tabs on your new investment in Corbus Pharmaceuticals Holdings, create a watchlist today.
Other Content You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.